Found 93 matching trials
B-free Multistage Trial PHASE4 The primary objective of the study is to evaluate the efficacy of a booster...
Show More Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Learn More & Join Trial
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection NA The purpose of this study is to measure the decay characteristics of HIV in...
Show More Location
St Vincent's Hospital
Learn More & Join Trial
Research on the Psychological Status of Patients With HIV-1 Infection N/A The goal of this observational study is to investigate the neuropsychologic...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients PHASE2 The HIV-2 is less common ie 1-2 million people in West Africa. HIV-2 does h...
Show More Location
Hôpital Bichat-Claude Bernard
Learn More & Join Trial
Raltegravir Switch for Toxicity or Adverse Events PHASE2 This study aims to verify the persistent control of the virus replication a...
Show More Location
Policlinico A. Gemelli
Learn More & Join Trial
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen PHASE2 The goal of this clinical study is to learn more about the effects of switc...
Show More Status
Active Not Recruiting
Location
Be Well Medical Center
Learn More & Join Trial
A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) PHASE3 This study will investigate the safety and efficacy of MK-0518 versus efavi...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily PHASE3 The purpose of this trial is to assess the non-inferior antiviral activity ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Key Link for Transmission Prevention NA This pilot study will assess the feasibility for the potential public healt...
Show More Location
Lighthouse Trust, Kamuzu Central Hospital
Learn More & Join Trial